CLASS II ONGOING Drug recall · Reported 2 Aug 2023 · FDA Enforcement Report
Oxacillin for Injection, USP per pharmacy, For Intravenous Use recalled
Sagent Pharmaceuticals is recalling Oxacillin for Injection, USP per pharmacy, For Intravenous Use, distributed nationwide in the US. The recall was initiated on 11 Jul 2023 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0937-2023
- FDA event ID
- 92678
- Recalling firm
- Sagent Pharmaceuticals, Schaumburg, IL
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 11 Jul 2023
- FDA classified
- 21 Jul 2023
- Reported
- 2 Aug 2023
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 11 Jul 2023 | Recall initiated by company | |
| 21 Jul 2023 | Classified by FDA | +10 days |
| 2 Aug 2023 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Oxacillin for Injection, USP, 10 gram per pharmacy Bulk Package bottle, For Intravenous Use, Rx only, packaged as a) NDC 25021-163-99 and b) novaplus NDC 25021-163-68, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. Made in India.
Where it was distributed
Nationwide in the USA
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility
Which lots are affected?
Lot: a) OXT202, exp 5/31/2025; OXT203, exp 5/31/2025; OXT301, exp 12/31/2025; b) OXT205, exp 6/30/2025; OXT204, exp 5/31/2025
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
2 other products · FDA event 92678This product is part of a recall event; the main page for the event is Oxacillin for Injection, USP per vial, For IV or IM Use recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Oxacillin for Injection, USP per vial, For IV or IM Use recalled | Sagent Pharmaceuticals | Sterility | Nationwide | |
| CLASS II | Oxacillin for Injection, USP per vial, For IV or IM Use recalled | Sagent Pharmaceuticals | Sterility | Nationwide |
More recalls from Sagent Pharmaceuticals
All 23| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Busulfan Injection, 60 mg per (6 mg per mL), mL Single-Dose Vials recalledBusulfan | Sagent Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS I | Docetaxel Injection, USP, 80 mg per (10 mg per mL) recalledDocetaxel | Sagent Pharmaceuticals | Particulate Matter | Nationwide |
| Drug | CLASS I | Docetaxel Injection, USP, 160 mg per (10 mg per mL) recalledDocetaxel | Sagent Pharmaceuticals | Particulate Matter | Nationwide |
| Drug | CLASS II | MethylPREDNISolone Acetate Injectable Suspension recalledMethylprednisolone Acetate | Sagent Pharmaceuticals | Particulate Matter | Nationwide |
| Drug | CLASS II | Oxacillin for Injection, USP per vial, For IV or IM Use recalled | Sagent Pharmaceuticals | Sterility | Nationwide |
Other Oxacillin recalls
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Oxacillin for Injection, USP per vial, For IV or IM Use recalled | Sagent Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Oxacillin for Injection, USP per vial, For IV or IM Use recalled | Sagent Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Oxacillin for Injection, USP per pharmacy , Buffered recalled | Sagent Pharmaceuticals | Particulate Matter | Nationwide |